4//SEC Filing
McNaughton Thomas 4
Accession 0001144204-18-017587
CIK 0001563665other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 5:06 PM ET
Size
7.1 KB
Accession
0001144204-18-017587
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
McNaughton Thomas
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-03-14+928→ 11,234 total - Exercise/Conversion
Restricted Stock Units
2018-03-14−928→ 2,784 totalExercise: $0.00From: 2018-03-14Exp: 2018-03-14→ Common Stock (928 underlying)
Footnotes (1)
- [F1]Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock.
Documents
Issuer
Biostage, Inc.
CIK 0001563665
Entity typeother
Related Parties
1- filerCIK 0001449450
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 5:06 PM ET
- Size
- 7.1 KB